Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SILDENAFIL R | 20MG | TABLET | Resolved | 2020-07-14 | 2020-07-15 | 120259 |
| TEVA-SILDENAFIL R | 20MG | TABLET | Resolved | 2020-08-18 | 2021-03-25 | 122442 |
| TEVA-SIMVASTATIN | 80MG | TABLET | Resolved | 2020-08-06 | 2021-04-15 | 121885 |
| TEVA-SIMVASTATIN | 40MG | TABLET | Resolved | 2024-01-11 | 2024-07-04 | 215722 |
| TEVA-SIMVASTATIN | 80MG | TABLET | Resolved | 2019-10-03 | 2020-09-03 | 95390 |
| TEVA-SIMVASTATIN | 5MG | TABLET | Resolved | 2020-01-24 | 2020-06-05 | 104319 |
| TEVA-SIMVASTATIN | 10MG | TABLET | Resolved | 2022-09-07 | 2023-06-21 | 168749 |
| TEVA-SIMVASTATIN | 5MG | TABLET | Resolved | 2023-07-11 | 2024-09-05 | 198303 |
| TEVA-SIMVASTATIN | 20MG | TABLET | Resolved | 2023-07-11 | 2024-06-27 | 198306 |
| TEVA-SIMVASTATIN | 20MG | TABLET | Resolved | 2023-07-11 | 2024-07-11 | 198309 |
| TEVA-SIMVASTATIN | 5MG | TABLET | Resolved | 2023-08-17 | 2024-09-05 | 202252 |
| TEVA-SIMVASTATIN | 10MG | TABLET | Resolved | 2023-10-05 | 2024-07-04 | 206401 |
| TEVA-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-10-19 | 2024-07-18 | 207518 |
| TEVA-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-01-12 | 2023-07-12 | 180912 |
| TEVA-SIMVASTATIN | 80MG | TABLET | Resolved | 2023-01-12 | 2023-06-21 | 180915 |
| TEVA-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-06-16 | 2023-06-21 | 195243 |
| TEVA-SIMVASTATIN | 20MG | TABLET | Resolved | 2017-08-02 | 2017-08-26 | 18004 |
| TEVA-SIMVASTATIN | 80MG | TABLET | Resolved | 2017-08-02 | 2017-09-19 | 18014 |
| TEVA-SITAGLIPTIN MALATE | 25MG | TABLET | Actual shortage | 2025-03-06 | 2025-04-10 | 252059 |
| TEVA-SITAGLIPTIN MALATE | 50MG | TABLET | Actual shortage | 2025-03-06 | 2025-04-10 | 252062 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-04-25 | 2025-04-25 | 255818 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 |